Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
![]() |
A systematic methodology review of fluorescence-guided cancer surgery to inform the development of a core master protocol and outcome setBMC cancer, 2024-06, Vol.24 (1), p.697-697 [Peer Reviewed Journal]COPYRIGHT 2024 BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-024-12386-4Full text available |
2 |
Material Type: Article
|
![]() |
Correction to: Capsular extension at ultrasound is associated with lateral lymph node metastasis in patients with papillary thyroid carcinoma: a retrospective studyBMC cancer, 2022-02, Vol.22 (1), p.194-194, Article 194 [Peer Reviewed Journal]COPYRIGHT 2022 BioMed Central Ltd. ;The Author(s) 2022 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-09303-y ;PMID: 35189858Full text available |
3 |
Material Type: Article
|
![]() |
Correction to: Mapping the EORTC QLQ-C30 to EQ-5D-3L in patients with breast cancerBMC cancer, 2022-01, Vol.22 (1), p.112-112, Article 112 [Peer Reviewed Journal]COPYRIGHT 2022 BioMed Central Ltd. ;The Author(s) 2022 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-09226-8 ;PMID: 35086517Full text available |
4 |
Material Type: Article
|
![]() |
TACE combined Lenvatinib plus Camrelizumab versus TACE alone in efficacy and safety for unresectable hepatocellular carcinoma: a propensity score-matching studyBMC cancer, 2024-06, Vol.24 (1), p.717-717 [Peer Reviewed Journal]COPYRIGHT 2024 BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-024-12484-3Full text available |
5 |
Material Type: Article
|
![]() |
Colorectal cancer liver metastases - a population-based study on incidence, management and survivalBMC cancer, 2018-01, Vol.18 (1), p.78-78, Article 78 [Peer Reviewed Journal]COPYRIGHT 2018 BioMed Central Ltd. ;COPYRIGHT 2018 BioMed Central Ltd. ;The Author(s). 2018 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-017-3925-x ;PMID: 29334918Full text available |
6 |
Material Type: Article
|
![]() |
Randomised phase II trial of trifluridine/tipiracilBMC cancer, 2023-08, Vol.23 (1) [Peer Reviewed Journal]COPYRIGHT 2023 BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-11199-1Full text available |
7 |
Material Type: Article
|
![]() |
The effects of short-term fasting on quality of life and tolerance to chemotherapy in patients with breast and ovarian cancer: a randomized cross-over pilot studyBMC cancer, 2018-04, Vol.18 (1), p.476-476, Article 476 [Peer Reviewed Journal]COPYRIGHT 2018 BioMed Central Ltd. ;COPYRIGHT 2018 BioMed Central Ltd. ;The Author(s). 2018 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-018-4353-2 ;PMID: 29699509Full text available |
8 |
Material Type: Article
|
![]() |
Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapyBMC cancer, 2023-02, Vol.23 (1), p.192-192, Article 192 [Peer Reviewed Journal]COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-10662-3 ;PMID: 36849943Full text available |
9 |
Material Type: Article
|
![]() |
Correction: Cytoplasmic poly(A)-binding protein 1 (PABPC1) is a prognostic biomarker to predict survival in nasopharyngeal carcinoma regardless of chemoradiotherapyBMC cancer, 2023-02, Vol.23 (1), p.190-190, Article 190 [Peer Reviewed Journal]COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-10666-z ;PMID: 36849899Full text available |
10 |
Material Type: Article
|
![]() |
C/EBP[beta] expression decreases in cervical cancer and leads to tumorigenesisBMC cancer, 2023-01, Vol.23 (1) [Peer Reviewed Journal]COPYRIGHT 2023 BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-023-10543-9Full text available |
11 |
Material Type: Article
|
![]() |
Correction: EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatmentBMC cancer, 2022-11, Vol.22 (1), p.1224-1224, Article 1224 [Peer Reviewed Journal]COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-10335-7 ;PMID: 36443715Full text available |
12 |
Material Type: Article
|
![]() |
Anticancer traits of chimeric antigen receptors cells as novel approaches for melanoma treatmentBMC cancer, 2022-11, Vol.22 (1) [Peer Reviewed Journal]COPYRIGHT 2022 BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-10320-0Full text available |
13 |
Material Type: Article
|
![]() |
Radiomics model based on contrast-enhanced computed tomography imaging for early recurrence monitoring after radical resection of AFP-negative hepatocellular carcinomaBMC cancer, 2024-06, Vol.24 (1), p.700-700 [Peer Reviewed Journal]COPYRIGHT 2024 BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-024-12436-xFull text available |
14 |
Material Type: Article
|
![]() |
Dose escalation of tolinapant in UK secondary care centresBMC cancer, 2024-06, Vol.24 (1) [Peer Reviewed Journal]COPYRIGHT 2024 BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-024-12310-wFull text available |
15 |
Material Type: Article
|
![]() |
The OVAREX study: Establishment of ex vivo ovarian cancer models to validate innovative therapies and to identify predictive biomarkersBMC cancer, 2024-06, Vol.24 (1), p.701-701 [Peer Reviewed Journal]COPYRIGHT 2024 BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-024-12429-wFull text available |
16 |
Material Type: Article
|
![]() |
A miRNA-disease association prediction model based on tree-path global feature extraction and fully connected artificial neural network with multi-head self-attention mechanismBMC cancer, 2024-06, Vol.24 (1), p.683-683 [Peer Reviewed Journal]COPYRIGHT 2024 BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-024-12420-5Full text available |
17 |
Material Type: Article
|
![]() |
Association of the SHOX2 and RASSF1A methylation levels with the pathological evolution of early-stage lung adenocarcinomaBMC cancer, 2024-06, Vol.24 (1), p.687-687 [Peer Reviewed Journal]COPYRIGHT 2024 BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-024-12452-xFull text available |
18 |
Material Type: Article
|
![]() |
Time-dependent efficacy analysis of first-line immunotherapies for advanced non-small cell lung cancerBMC cancer, 2024-06, Vol.24 (1), p.684-684 [Peer Reviewed Journal]COPYRIGHT 2024 BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-024-12439-8Full text available |
19 |
Material Type: Article
|
![]() |
PPIH acts as a potential predictive biomarker for patients with common solid tumorsBMC cancer, 2024-06, Vol.24 (1), p.681-681 [Peer Reviewed Journal]COPYRIGHT 2024 BioMed Central Ltd. ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-024-12446-9Full text available |
20 |
Material Type: Article
|
![]() |
Precancerous cervical lesion and associated factors among HIV-infected women in Ethiopia: systematic review and meta- analysisBMC cancer, 2024-06, Vol.24 (1), p.678-678 [Peer Reviewed Journal]COPYRIGHT 2024 BioMed Central Ltd. ;The Author(s) 2024 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-024-12462-9 ;PMID: 38831404Full text available |